MedTrace Logo

Statewide System and Organizational Strategy for EBP Implementation

NCT05344534 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 479

Last updated 2026-01-15

No results posted yet for this study

Summary

This project will test an implementation strategy that seeks to align system, organization, and clinic leadership strategies to implement and sustain the Lyssn artificial intelligence (AI) quality assurance platform to support implementation of Motivational Interviewing (MI) and evidence-based practice (EBP) for substance use disorders. The Leadership and Organizational Change for Implementation - System Level (LOCI-SL) strategy seeks to engage policymakers and funders at the system level to improve implementation leadership, climate, provider attitudes and behaviors at the provider organization level to enhance implementation climate for EBP. LOCI-SL will be tested in a statewide addiction service system through clinics in community based behavioral health organizations.

Conditions

  • Control
  • Experimental

Interventions

BEHAVIORAL

Leadership and Organizational Change for Implementation

LOCI is data driven leadership development and coaching for clinic managers and working with agency executives and middle managers to foster a strategic implementation climate

Sponsors & Collaborators

  • University of Central Florida

    collaborator OTHER

  • Pacific Institute for Research and Evaluation

    collaborator OTHER

  • Chestnut Health Systems

    collaborator OTHER

  • University of California, San Diego

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-30
Primary Completion
2025-01-30
Completion
2025-01-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05344534 on ClinicalTrials.gov